Virtu KCG Holdings’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$79K Buy
720,158
+670,753
+1,358% +$24.9K ﹤0.01% 2480
2017
Q1
$1K Sell
49,405
-98,883
-67% -$1.82K ﹤0.01% 3062
2016
Q4
$3K Buy
+148,288
New +$5.71K ﹤0.01% 3338
2016
Q3
Sell
-36,792
Closed -$1K 3728
2016
Q2
$1K Buy
+36,792
New +$2.43K ﹤0.01% 2900
2015
Q3
Sell
-191,436
Closed -$33K 4106
2015
Q2
$33K Buy
+191,436
New +$28.6K ﹤0.01% 3135

Other funds holding OPXAW

Virtu KCG Holdings's OPXAW Position: Q2 2017 in Review

Virtu KCG Holdings increased its Opexa Therapeutics, Inc. (OPXAW) stake by 1,358% in Q2 2017, buying an estimated $24.9K and bringing the position to 720,158 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

Virtu KCG Holdings first reported a position in OPXAW in Q2 2015 and has held it in 5 quarters since. 4 funds tracked by Wall St. Rank hold OPXAW as of Q2 2017.

  • Virtu KCG Holdings held 720,158 shares of Opexa Therapeutics, Inc. worth $79K as of Q2 2017.
  • Virtu KCG Holdings bought 670,753 Opexa Therapeutics, Inc. shares in Q2 2017, an estimated $24.9K.
  • Opexa Therapeutics, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2480 holding.
  • Virtu KCG Holdings first reported a position in Opexa Therapeutics, Inc. in Q2 2015 and has held it in 5 quarters since.
  • 4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.